By Kailyn Rhone
Shares of Champions Oncology jumped after the company swung to a profit and reported higher revenue in the latest quarter due to bookings growth and operational improvements.
The company's stock rose 13% to $6.62 in after-hours trading Wednesday. Shares were up almost 4% for the year through the day's close.
The technology-enabled research company on Wednesday posted a profit of $728,000, or 5 cents a share, up from a loss of $2 million, or 15 cents a share, in the same quarter a year ago.
Sales grew 17% to $13.5 million from $11.6 million a year earlier, driven by growth in bookings and operational improvements and efficiencies implemented in the quarter.
Cost of oncology services rose 12.2% to $7.4 million from $6.6 million a year ago, due to an increase in mice and lab costs to help revenue growth.
"We remain cautiously optimistic that the pharma and biotech environment is improving which will continue to contribute to our long-term growth," Chief Executive Ronnie Morris said.
Write to Kailyn Rhone at kailyn.rhone@wsj.com
(END) Dow Jones Newswires
December 11, 2024 17:32 ET (22:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。